KCNK12 Protein

KCNK12 Protein (Potassium Two Pore Domain Channel Subfamily K Member 12)

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNK12 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Potassium Two Pore Domain Channel Subfamily K Member 12</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/kcnk12">KCNK12</a> (also called K2P12 or THIK-2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9HBU6">Q9HBU6</a></td></tr>
<tr><td><strong>Alternative Names</strong></td><td>THIK-2, K2P12.1, Two-pore domain potassium channel THIK-2</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~38 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Tandem pore domain potassium channel (K2P) family</td></tr>
</table>
</div>

Overview

KCNK12 (also known as THIK-2) is a member of the two-pore domain potassium (K2P) channel family that generates background potassium currents essential for neuronal excitability, resting membrane potential maintenance, and cellular responses to various physiological stimuli. KCNK12 is expressed throughout the brain and has been increasingly implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurological disorders.

Structure and Function

K2P Channel Architecture

KCNK12 Protein (Potassium Two Pore Domain Channel Subfamily K Member 12)

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNK12 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Potassium Two Pore Domain Channel Subfamily K Member 12</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/kcnk12">KCNK12</a> (also called K2P12 or THIK-2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9HBU6">Q9HBU6</a></td></tr>
<tr><td><strong>Alternative Names</strong></td><td>THIK-2, K2P12.1, Two-pore domain potassium channel THIK-2</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~38 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Tandem pore domain potassium channel (K2P) family</td></tr>
</table>
</div>

Overview

KCNK12 (also known as THIK-2) is a member of the two-pore domain potassium (K2P) channel family that generates background potassium currents essential for neuronal excitability, resting membrane potential maintenance, and cellular responses to various physiological stimuli. KCNK12 is expressed throughout the brain and has been increasingly implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurological disorders.

Structure and Function

K2P Channel Architecture

KCNK12 shares the characteristic K2P channel structure:

• Four transmembrane segments: Two pore-forming domains (P1 and P2) create the ion conduction pathway
• Two selectivity filters: Potassium-selective pores allow K+ passage
• Extracellular loops: Form the channel entrance and determine ion selectivity
• Cytoplasmic termini: Contain regulatory domains that modulate channel activity

Gating and Regulation

KCNK12 is regulated by multiple physiological mechanisms:

• Halothane sensitivity: Activated by volatile anesthetics through specific binding sites
• Hypoxia responses: Oxygen levels directly modulate channel activity
• pH sensitivity: Both intracellular and extracellular pH affect channel gating
• Lipid modulation: Phospholipids and fatty acids regulate channel activity

Role in Neurodegeneration

Alzheimer's Disease

KCNK12 contributes to AD pathophysiology through multiple pathways:

• Neuronal excitability: Altered KCNK12 affects resting membrane potential and excitability
• Calcium dysregulation: Changes in potassium flux impact calcium homeostasis
• Synaptic transmission: Modulates synaptic activity and plasticity
• Neuroprotection: Loss of KCNK12 may increase vulnerability to excitotoxic injury

Parkinson's Disease

In Parkinson's disease, KCNK12 is involved in critical processes:

• Dopaminergic signaling: Regulates excitability of [substantia nigra](/brain-regions/substantia-nigra) [neurons](/entities/neurons)
• Oxidative stress: Channels modulate cellular responses to oxidative damage
• Mitochondrial function: Interactions with mitochondrial potassium channels
• Neuroinflammation: Microglial KCNK12 influences inflammatory responses

Neuronal Survival

KCNK12 regulates neuronal survival through essential mechanisms:

Therapeutic Potential

Channel Modulation Strategies

KCNK12 is a potential therapeutic target for neurodegenerative diseases:

• Activators: Channel openers may provide neuroprotection
• Inhibitors: Blockers may reduce pathological hyperexcitability
• Selectivity: Developing subtype-selective compounds for specific disorders

Drug Development Challenges

Key challenges remain in targeting KCNK12:

• [Blood-brain barrier](/entities/blood-brain-barrier): Achieving adequate CNS drug delivery
• Isoform selectivity: Distinguishing between 15 K2P family members
• Functional complexity: Understanding diverse regulatory mechanisms

See Also

• Potassium Channels in Neurodegeneration
• Neuronal Excitability in AD
• [Excitotoxicity Mechanisms](/mechanisms/excitotoxicity)
• Parkinson's Disease Pathogenesis

References